Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study

Abstract This study aimed to evaluate the efficacy and safety of induction immunochemotherapy followed by definitive chemoradiotherapy (CRT) for unresectable locally advanced non‐small cell lung cancer (LA‐NSCLC). We identified unresectable stage III NSCLC patients who received induction immunochemo...

Full description

Bibliographic Details
Main Authors:	Leilei Wu, Bo Cheng, Xiaojiang Sun, Zhenshan Zhang, Jingjing Kang, Yun Chen, Qinghua Xu, Shuangyan Yang, Yujie Yan, Shengxiang Ren, Caicun Zhou, Yaping Xu
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	MedComm
Subjects:	definitive chemoradiotherapy Induction immunochemotherapy survival unresectable LA‐NSCLC
Online Access:	https://doi.org/10.1002/mco2.501

Similar Items

Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China
by: Tian X, et al.
Published: (2020-05-01)

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
by: Magdalena Zaborowska-Szmit, et al.
Published: (2021-09-01)

Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database
by: Liangyun Xie, et al.
Published: (2024-01-01)

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
by: Hideaki Bando, et al.
Published: (2020-04-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
by: Lei Xu, et al.
Published: (2022-11-01)

Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis
by: Zi-Meng Wang, et al.
Published: (2023-04-01)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
by: Tomohiro Enokida, et al.
Published: (2020-03-01)

Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study
by: Takamichi Igarashi, et al.
Published: (2023-01-01)

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma
by: Zhu Ji, et al.
Published: (2013-01-01)

Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer
by: Chaoyuan Liu, et al.
Published: (2023-02-01)

Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis
by: Yuko Mataki, et al.
Published: (2021-03-01)

Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer
by: Bo Qiu, et al.
Published: (2016-07-01)

Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients
by: Agnes Koch, et al.
Published: (2022-03-01)

Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment
by: VPCP Toledo, et al.
Published: (2001-01-01)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
by: Ganesh Yadagiri, et al.
Published: (2023-05-01)

Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome
by: Ivane Kiladze, et al.
Published: (2023-03-01)

Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?
by: Yuanheng Huang, et al.
Published: (2023-05-01)

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
by: Ranpu Wu, et al.
Published: (2021-07-01)

Neoadjuvant immunochemotherapy for pulmonary large-cell neuroendocrine carcinoma: case report
by: Chang Xu, et al.
Published: (2024-04-01)

Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis
by: Jianing Wang, et al.
Published: (2021-09-01)

A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
by: Tian Zhang, et al.
Published: (2022-08-01)

Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
by: Magnus Nilsson, et al.
Published: (2022-07-01)

Induction chemoimmunotherapy may improve outcomes of chemoradiotherapy in patients with unresectable stage III NSCLC
by: Song Guan, et al.
Published: (2023-11-01)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
by: Hyehyun Jeong, et al.
Published: (2021-03-01)

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient
by: Yoshio Okano, et al.
Published: (2022-02-01)

Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer
by: Jacqueline V. Aredo, et al.
Published: (2022-01-01)

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
by: Ming-Wei Ma, et al.
Published: (2018-08-01)

Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer
by: Yanfen Zheng, et al.
Published: (2022-06-01)

Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Koichi Yagi, et al.
Published: (2021-07-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
by: Yang Li, et al.
Published: (2021-11-01)

Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease
by: Bruno Mendes Roatt, et al.
Published: (2014-06-01)

The role of chemoradiotherapy and immunotherapy in stage III NSCLC
by: Zsuzsanna Orosz, et al.
Published: (2024-04-01)

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
by: Xiaofei Zhang, et al.
Published: (2023-02-01)

Moderately Escalated Hypofractionated (Chemo)Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
by: Vittorio eDonato, et al.
Published: (2013-11-01)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis
by: Meng Yuan, et al.
Published: (2021-12-01)

Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
by: Chia-Chin Li, et al.
Published: (2021-04-01)

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)
by: Isabelle Martel-Lafay, et al.
Published: (2021-09-01)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
by: Francesca De Felice, et al.
Published: (2021-05-01)

Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study
by: Chen-Yuan Lin, et al.
Published: (2022-08-01)